Pioneering the Next Frontier of EV Bioengineering

EVIA focuses on extracellular vesicles (”EV”) based therapeutics

We are committed to developing innovative drug candidates backed by cutting-edge science. We focus on creating drugs that have the potential to change the lives of patients with diseases for which there are few or no treatment options.

​

EVs, including exosomes, are responsible for intercellular communication via their bioactive substances. In living organisms, secreted vesicles are transported through bodily fluids where they deliver functional molecules to receiving cells. Click here for details.